BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24551214)

  • 21. Serum hepatitis B surface antigen is correlated with intrahepatic total HBV DNA and cccDNA in treatment-naïve patients with chronic hepatitis B but not in patients with HBV related hepatocellular carcinoma.
    Wang M; Qiu N; Lu S; Xiu D; Yu J; Wang XT; Lu F; Li T; Liu X; Zhuang H
    J Med Virol; 2013 Feb; 85(2):219-27. PubMed ID: 23168998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum HBV RNA correlated with intrahepatic cccDNA more strongly than other HBV markers during peg-interferon treatment.
    Wang X; Chi X; Wu R; Xu H; Gao X; Yu L; Liu L; Zhang M; Tan Y; Niu J; Jin Q
    Virol J; 2021 Jan; 18(1):4. PubMed ID: 33407619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.
    Chan HL; Wong VW; Tse AM; Tse CH; Chim AM; Chan HY; Wong GL; Sung JJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1462-8. PubMed ID: 18054753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients.
    García-López M; Lens S; Pallett LJ; Testoni B; Rodríguez-Tajes S; Mariño Z; Bartres C; García-Pras E; Leonel T; Perpiñán E; Lozano JJ; Rodríguez-Frías F; Koutsoudakis G; Zoulim F; Maini MK; Forns X; Pérez-Del-Pulgar S
    J Hepatol; 2021 May; 74(5):1064-1074. PubMed ID: 33278456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HBsAg levels in HBeAg-positive chronic hepatitis B patients with different immune conditions.
    Zhang YM; Yang YD; Jia HY; Zeng LY; Yu W; Zhou N; Li LJ
    World J Gastroenterol; 2014 Apr; 20(15):4407-13. PubMed ID: 24764680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms downstream of reverse transcription reduce serum levels of HBV DNA but not of HBsAg in chronic hepatitis B virus infection.
    Larsson SB; Malmström S; Hannoun C; Norkrans G; Lindh M
    Virol J; 2015 Dec; 12():213. PubMed ID: 26645241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The potential use of serum HBV RNA to guide the functional cure of chronic hepatitis B].
    Lu FM; Wang J; Chen XM; Jiang JN; Zhang WH; Zhao JM; Ren H; Hou JL; Xia NS
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):105-110. PubMed ID: 28297795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B.
    Ramachandran J; Ismail AM; Chawla G; Fletcher GJ; Goel A; Eapen CE; Abraham P
    Indian J Gastroenterol; 2014 Mar; 33(2):131-5. PubMed ID: 24052375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of covalently closed circular hepatitis B virus DNA in chronic hepatitis B patients.
    Wong DK; Yuen MF; Yuan H; Sum SS; Hui CK; Hall J; Lai CL
    Hepatology; 2004 Sep; 40(3):727-37. PubMed ID: 15349913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
    Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
    Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBsAg titers in the different phases of hepatitis B infection in Syrian patients.
    Antaki N; Zeidane N; Alhaj N; Hadad M; Baroudi O; Antaki F; Abouharb R; Haffar S; Abdelwahab J; Alideeb S; Asaad F; Aljesri A; Doghman D; Aaraj R; Ibrahim N; Ali A; Assil M; Sabah H; Katranji N; Kebbewar K
    J Clin Virol; 2012 Jan; 53(1):60-4. PubMed ID: 22079974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.
    Zeng LY; Lian JS; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
    World J Gastroenterol; 2014 Jul; 20(27):9178-84. PubMed ID: 25083092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Establishment of an HBV chronic hepatitis B infection mouse model by vivo transduction of HBV cccDNA].
    Zhao T; Li X; Yin W; Cai X; Zhang W; Chen F; Lai G; Huang A
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):260-5. PubMed ID: 25173223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transition to HBeAg-negative chronic hepatitis B virus infection is associated with reduced cccDNA transcriptional activity.
    Suslov A; Meier MA; Ketterer S; Wang X; Wieland S; Heim MH
    J Hepatol; 2021 Apr; 74(4):794-800. PubMed ID: 33188905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrahepatic innate immune response pathways are downregulated in untreated chronic hepatitis B.
    Lebossé F; Testoni B; Fresquet J; Facchetti F; Galmozzi E; Fournier M; Hervieu V; Berthillon P; Berby F; Bordes I; Durantel D; Levrero M; Lampertico P; Zoulim F
    J Hepatol; 2017 May; 66(5):897-909. PubMed ID: 28043874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The change of the quantitative HBsAg level during the natural course of chronic hepatitis B.
    Kim YJ; Cho HC; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
    Liver Int; 2011 Jul; 31(6):817-23. PubMed ID: 21645212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
    Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
    Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy.
    Erken R; Zaaijer HL; Willemse SB; Bakker E; Takkenberg BB; Reesink HW; Kootstra NA
    Ann Hepatol; 2021 Dec; 26():100540. PubMed ID: 34583061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrahepatic response markers in chronic hepatitis B patients treated with peginterferon alpha-2a and adefovir.
    Takkenberg B; Terpstra V; Zaaijer H; Weegink C; Dijkgraaf M; Jansen P; Beld M; Reesink H
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1527-35. PubMed ID: 21557773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.
    Nguyen T; Thompson AJ; Bowden S; Croagh C; Bell S; Desmond PV; Levy M; Locarnini SA
    J Hepatol; 2010 Apr; 52(4):508-13. PubMed ID: 20206400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.